Inactivating mutations of the bona fide TSG STK11 (i.e., LKB1; serine/threonine kinase 11) are common in lung cancer, modulate differentiation and metastasis in vivo, and have been observed more frequently patients with smoking history (29–31). This evidence concerns the gene STK11 and lung carcinoma.